260 related articles for article (PubMed ID: 25631631)
1. Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes.
Chen W; Wang D; Du X; He Y; Chen S; Shao Q; Ma C; Huang B; Chen A; Zhao P; Qu X; Li X
Med Oncol; 2015 Mar; 32(3):43. PubMed ID: 25631631
[TBL] [Abstract][Full Text] [Related]
2. AS602801 sensitizes glioma cells to temozolomide and vincristine by blocking gap junction communication between glioma cells and astrocytes.
Zhang S; Gong Y; Wang H; Li Z; Huang Y; Fu X; Xiang P; Fan T
J Cell Mol Med; 2021 Apr; 25(8):4062-4072. PubMed ID: 33609076
[TBL] [Abstract][Full Text] [Related]
3. Astrocytes protect glioma cells from chemotherapy and upregulate survival genes via gap junctional communication.
Lin Q; Liu Z; Ling F; Xu G
Mol Med Rep; 2016 Feb; 13(2):1329-35. PubMed ID: 26676970
[TBL] [Abstract][Full Text] [Related]
4. Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43‑mediated gap junction intercellular communication.
Wang L; Peng Y; Peng J; Shao M; Ma L; Zhu Z; Zhong G; Xia Z; Huang H
Int J Oncol; 2018 Jan; 52(1):295-304. PubMed ID: 29115581
[TBL] [Abstract][Full Text] [Related]
5. Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway.
Han S; Li Z; Master LM; Master ZW; Wu A
Br J Cancer; 2014 Sep; 111(7):1400-9. PubMed ID: 25093489
[TBL] [Abstract][Full Text] [Related]
6. Combination of temozolomide and Taxol exerts a synergistic inhibitory effect on Taxol‑resistant glioma cells via inhibition of glucose metabolism.
Guan DG; Chen HM; Liao SF; Zhao TZ
Mol Med Rep; 2015 Nov; 12(5):7705-11. PubMed ID: 26459853
[TBL] [Abstract][Full Text] [Related]
7. Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway.
Gielen PR; Aftab Q; Ma N; Chen VC; Hong X; Lozinsky S; Naus CC; Sin WC
Neuropharmacology; 2013 Dec; 75():539-48. PubMed ID: 23688923
[TBL] [Abstract][Full Text] [Related]
8. Increased invasive capacity of connexin43-overexpressing malignant glioma cells.
Zhang W; Nwagwu C; Le DM; Yong VW; Song H; Couldwell WT
J Neurosurg; 2003 Dec; 99(6):1039-46. PubMed ID: 14705732
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z
Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone and levetiracetam reduce hetero-cellular gap-junctional coupling between F98 glioma cells and glial cells in vitro.
Ismail FS; Moinfar Z; Prochnow N; Dambach H; Hinkerohe D; Haase CG; Förster E; Faustmann PM
J Neurooncol; 2017 Feb; 131(3):469-476. PubMed ID: 27848138
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis.
Sehm T; Rauh M; Wiendieck K; Buchfelder M; Eyüpoglu IY; Savaskan NE
Oncotarget; 2016 Nov; 7(46):74630-74647. PubMed ID: 27612422
[TBL] [Abstract][Full Text] [Related]
12. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.
Pyrko P; Schönthal AH; Hofman FM; Chen TC; Lee AS
Cancer Res; 2007 Oct; 67(20):9809-16. PubMed ID: 17942911
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.
Chai KM; Wang CY; Liaw HJ; Fang KM; Yang CS; Tzeng SF
Oncotarget; 2014 Nov; 5(21):10901-15. PubMed ID: 25337721
[TBL] [Abstract][Full Text] [Related]
14. Effects of Connexin43 Overexpression on U251 Cell Growth, Migration, and Apoptosis.
Lu J; Yu M; Lin Z; Lue S; Zhang H; Zhao H; Xu Y; Liu H
Med Sci Monit; 2017 Jun; 23():2917-2923. PubMed ID: 28615614
[TBL] [Abstract][Full Text] [Related]
15. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
16. miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
Wang J; Sai K; Chen FR; Chen ZP
Cancer Chemother Pharmacol; 2013 Jul; 72(1):147-58. PubMed ID: 23645289
[TBL] [Abstract][Full Text] [Related]
17. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.
Hatipoglu G; Hock SW; Weiss R; Fan Z; Sehm T; Ghoochani A; Buchfelder M; Savaskan NE; Eyüpoglu IY
Cancer Sci; 2015 Feb; 106(2):160-70. PubMed ID: 25458015
[TBL] [Abstract][Full Text] [Related]
18. Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells.
Shen D; Guo CC; Wang J; Qiu ZK; Sai K; Yang QY; Chen YS; Chen FR; Wang J; Panasci L; Chen ZP
Oncol Rep; 2015 Nov; 34(5):2715-21. PubMed ID: 26329778
[TBL] [Abstract][Full Text] [Related]
19. TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells.
Zhuang D; Liu Y; Mao Y; Gao L; Zhang H; Luan S; Huang F; Li Q
Int J Cancer; 2012 Jan; 130(2):309-18. PubMed ID: 21328340
[TBL] [Abstract][Full Text] [Related]
20. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells.
Lin JH; Takano T; Cotrina ML; Arcuino G; Kang J; Liu S; Gao Q; Jiang L; Li F; Lichtenberg-Frate H; Haubrich S; Willecke K; Goldman SA; Nedergaard M
J Neurosci; 2002 Jun; 22(11):4302-11. PubMed ID: 12040035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]